newsfilter
← Latest News
Business Wire·

Elan To Proceed with Formal Sale Process

DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE:ELN) (Elan or the Company) today announced that it is proceeding with a formal sale process in light of the expressions of interest received to date. As part of this process, Royalty Pharma will be invited to participate if they so wish. Accordingly, shareholders are urged not to tender into the current Royalty Pharma hostile offer.